Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04533529
What this trial is testing

Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 588
Large-scale testing (Phase 3)Study completedNCT05061719
What this trial is testing

An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 812
Large-scale testing (Phase 3)Study completedNCT01370499
What this trial is testing

LY2216684 in Participants With Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 288
Post-approval studies (Phase 4)Study completedNCT02058693
What this trial is testing

Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Rush University Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT00844922
What this trial is testing

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Who this might be right for
Depressive DisordersPsychotic DisordersDepression
Merck Sharp & Dohme LLC 16
Large-scale testing (Phase 3)Study completedNCT03697603
What this trial is testing

Brexpiprazole in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Co., Ltd. 740
Large-scale testing (Phase 3)Ended earlyNCT04855747
What this trial is testing

Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive DisorderDepression
Levomecor Inc. 236
Not applicableStudy completedNCT00953745
What this trial is testing

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Washington University School of Medicine 43
Post-approval studies (Phase 4)Study completedNCT01750359
What this trial is testing

Efficacy and Safety Curcumin in Depression

Who this might be right for
Major Depression
Vladimir Lerner 40
Large-scale testing (Phase 3)Study completedNCT03739203
What this trial is testing

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 752
Large-scale testing (Phase 3)Study completedNCT05455684
What this trial is testing

Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 513
Testing effectiveness (Phase 2)Study completedNCT01941043
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Avalo Therapeutics, Inc. 1,357
Testing effectiveness (Phase 2)Study completedNCT01447576
What this trial is testing

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,036
Large-scale testing (Phase 3)Study completedNCT02600507
What this trial is testing

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 529
Not applicableNot Yet RecruitingNCT07645807
What this trial is testing

Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.

Who this might be right for
Adjunct in the Treatment of Depressive Disorder
Sichuan Credit Pharmaceutical Co., Ltd. 80
Not applicableStudy completedNCT00285727
What this trial is testing

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression

Who this might be right for
Depressive Disorder, Major
Stanford University 60
Large-scale testing (Phase 3)Study completedNCT01715805
What this trial is testing

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Forest Laboratories 1,022
Large-scale testing (Phase 3)Study completedNCT01360645
What this trial is testing

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 826
Large-scale testing (Phase 3)Ended earlyNCT06011577
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD

Who this might be right for
Major Depressive DisorderDepression
Levomecor Inc. 27
Large-scale testing (Phase 3)Study completedNCT01360866
What this trial is testing

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 2,944
Next Page